Establishment and evaluation of a triple-color human papillomavirus pseudovirion neutralization assay
Objective: To establish a triple-color pseudovirion-based neutralization assay (PBNA) and evaluate its capability of detecting immunogenicity of the sera generated by the immunization of HPV 9-valent vaccine. Methods: HPV pseudovirus (PsVs) 6/11/16/18/31/33/45/52/58 with the encapsidated fluorescence expressing red fluorescent plasmid N31-MCHREEY, green fluorescent N31-EGFP or blue fluorescent N31-mTagBFP were generated. The concentration of HPV PsVs and the infection titers of HPV PsVs were detected by double-antibody sandwich ELISA and TCID(50), respectively. The single- and triple color HPV 16/33/45 PsVs were used to detect the neutralization titers of mice sera immunized with HPV 9-valent vaccine and confirmed the accuracy and specificity of the triple-color PBNAs. Then, the single- and triple color HPV 6/11/18/31/33/45/52/58 PsVs were employed to detect the neutralization titers of cynomolgus macaques sera immunized with HPV 9-valent vaccine and determined whether the triple-color PBNAs could be applied to evaluate the immunogenicity of the sera generated by the immunization of HPV9-valent vaccine. Results: The concentration of HPV16 PsVs encapsulating green, red or blue fluorescent plasmid was 5.0 to 6.0 μg/ml and HPV6/11/18/31/33/45/52/59 triple-color HPV PsVs was about 1.0 to 3.0 μg/ml. 9 types HPV PsVs containing EGFP, Mcherry or mTagBFP reporter plasmid were obtained and the concentration can meet the need of neutralization detection. 9 types single-color fluorescent HPV PsVs had similar infectivity against 293FT cells with the infection titer values between 1×10(4) and 1×10(5). The results of PBNAs showed that there was no significant difference in the anti-HPV neutralization titers of mice sera induced by HPV 9-valent vaccine between single-color and triple-color HPV16/33/45 PsVs (P>0.05). Similarly, there was also no significant difference in the anti-HPV neutralization titers of cynomolgus macaques sera induced by HPV 9-valent vaccine between single-color and triple-color HPV6/11/18/31/33/45/52/58 PsVs (P>0.05). Conclusion: We successfully established the triple-color PBNAs and verified the accuracy and specificity of triple-color PBNAs consistent with single-color PBNAs. The triple-color PBNAs can be applied to evaluate the immunogenicity of HPV 9-valent vaccine's immune serum.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
---|---|
Enthalten in: |
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine - 52(2018), 10 vom: 06. Okt., Seite 1039-1044 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Wei, S P [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibodies, Viral |
---|
Anmerkungen: |
Date Completed 12.04.2019 Date Revised 12.04.2019 published: Print Citation Status MEDLINE |
---|
doi: |
10.3760/cma.j.issn.0253-9624.2018.10.014 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM290256410 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM290256410 | ||
003 | DE-627 | ||
005 | 20231225064334.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.3760/cma.j.issn.0253-9624.2018.10.014 |2 doi | |
028 | 5 | 2 | |a pubmed24n0967.xml |
035 | |a (DE-627)NLM290256410 | ||
035 | |a (NLM)30392324 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Wei, S P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Establishment and evaluation of a triple-color human papillomavirus pseudovirion neutralization assay |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.04.2019 | ||
500 | |a Date Revised 12.04.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Objective: To establish a triple-color pseudovirion-based neutralization assay (PBNA) and evaluate its capability of detecting immunogenicity of the sera generated by the immunization of HPV 9-valent vaccine. Methods: HPV pseudovirus (PsVs) 6/11/16/18/31/33/45/52/58 with the encapsidated fluorescence expressing red fluorescent plasmid N31-MCHREEY, green fluorescent N31-EGFP or blue fluorescent N31-mTagBFP were generated. The concentration of HPV PsVs and the infection titers of HPV PsVs were detected by double-antibody sandwich ELISA and TCID(50), respectively. The single- and triple color HPV 16/33/45 PsVs were used to detect the neutralization titers of mice sera immunized with HPV 9-valent vaccine and confirmed the accuracy and specificity of the triple-color PBNAs. Then, the single- and triple color HPV 6/11/18/31/33/45/52/58 PsVs were employed to detect the neutralization titers of cynomolgus macaques sera immunized with HPV 9-valent vaccine and determined whether the triple-color PBNAs could be applied to evaluate the immunogenicity of the sera generated by the immunization of HPV9-valent vaccine. Results: The concentration of HPV16 PsVs encapsulating green, red or blue fluorescent plasmid was 5.0 to 6.0 μg/ml and HPV6/11/18/31/33/45/52/59 triple-color HPV PsVs was about 1.0 to 3.0 μg/ml. 9 types HPV PsVs containing EGFP, Mcherry or mTagBFP reporter plasmid were obtained and the concentration can meet the need of neutralization detection. 9 types single-color fluorescent HPV PsVs had similar infectivity against 293FT cells with the infection titer values between 1×10(4) and 1×10(5). The results of PBNAs showed that there was no significant difference in the anti-HPV neutralization titers of mice sera induced by HPV 9-valent vaccine between single-color and triple-color HPV16/33/45 PsVs (P>0.05). Similarly, there was also no significant difference in the anti-HPV neutralization titers of cynomolgus macaques sera induced by HPV 9-valent vaccine between single-color and triple-color HPV6/11/18/31/33/45/52/58 PsVs (P>0.05). Conclusion: We successfully established the triple-color PBNAs and verified the accuracy and specificity of triple-color PBNAs consistent with single-color PBNAs. The triple-color PBNAs can be applied to evaluate the immunogenicity of HPV 9-valent vaccine's immune serum | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HPV triple-color pseudovirus | |
650 | 4 | |a Human papillomavirus | |
650 | 4 | |a Immune sera | |
650 | 4 | |a Neutralization tests | |
650 | 4 | |a Vaccine | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a Papillomavirus Vaccines |2 NLM | |
700 | 1 | |a Fan, F |e verfasserin |4 aut | |
700 | 1 | |a Chen, J |e verfasserin |4 aut | |
700 | 1 | |a Liu, X L |e verfasserin |4 aut | |
700 | 1 | |a Yang, Y R |e verfasserin |4 aut | |
700 | 1 | |a Wang, Z P |e verfasserin |4 aut | |
700 | 1 | |a Song, S |e verfasserin |4 aut | |
700 | 1 | |a Li, Z H |e verfasserin |4 aut | |
700 | 1 | |a Wei, M X |e verfasserin |4 aut | |
700 | 1 | |a Wang, D N |e verfasserin |4 aut | |
700 | 1 | |a Li, S W |e verfasserin |4 aut | |
700 | 1 | |a Xia, N S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine |d 1981 |g 52(2018), 10 vom: 06. Okt., Seite 1039-1044 |w (DE-627)NLM000467448 |x 0253-9624 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2018 |g number:10 |g day:06 |g month:10 |g pages:1039-1044 |
856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.issn.0253-9624.2018.10.014 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2018 |e 10 |b 06 |c 10 |h 1039-1044 |